Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Huinan Huifa Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of Traditional Chinese Medicine (TCM) and chemical drugs. The company operates several production lines certified under Good Manufacturing Practice (GMP) standards, producing various dosage forms including tablets, capsules, granules, and oral liquids. Its product portfolio primarily targets therapeutic areas such as cardiovascular health, respiratory ailments, and digestive system disorders. Huifa Pharmaceutical is a key player in the Jilin province pharmaceutical cluster, leveraging regional herbal resources to supply the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Huinan Huifa.